UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 7.643

Sortiert nach

Overview of the 8th Edition TNM Classification for Head and Neck Cancer

Current treatment options in oncology, 2017-07, Vol.18 (7), p.40-40, Article 40

2017

Link zum Volltext

Verfügbarkeit prüfen

EGFR-targeted therapies in the post-genomic era

Cancer and metastasis reviews, 2017-09, Vol.36 (3), p.463-473

2017

Link zum Volltext

Verfügbarkeit prüfen

Diagnostic performance of post-treatment FDG PET or FDG PET/CT imaging in head and neck cancer: a systematic review and meta-analysis

European journal of nuclear medicine and molecular imaging, 2011-11, Vol.38 (11), p.2083-2095

2011

Link zum Volltext

Verfügbarkeit prüfen

Correlation Between the Pretherapeutic Neutrophil to Lymphocyte Ratio and the Pathologic Response to Neoadjuvant Chemotherapy in Patients With Advanced Esophageal Cancer

World journal of surgery, 2012-03, Vol.36 (3), p.617-622

2012

Link zum Volltext

Verfügbarkeit prüfen

Current Treatment Options for Metastatic Head and Neck Cancer

Current treatment options in oncology, 2012-03, Vol.13 (1), p.35-46

2012

Link zum Volltext

Verfügbarkeit prüfen

Optimal Dosing Strategy for Fluorescence-Guided Surgery with Panitumumab-IRDye800CW in Head and Neck Cancer

Molecular imaging and biology, 2020-02, Vol.22 (1), p.156-164

2020

Link zum Volltext

Verfügbarkeit prüfen

mTOR co-targeting strategies for head and neck cancer therapy

Cancer and metastasis reviews, 2017-09, Vol.36 (3), p.491-502

2017

Link zum Volltext

Verfügbarkeit prüfen

Risk factors for survival and distant metastasis in 125 patients with head and neck adenoid cystic carcinoma undergoing primary surgery

Journal of cancer research and clinical oncology, 2020-05, Vol.146 (5), p.1343-1350

2020

Link zum Volltext

Verfügbarkeit prüfen

A phase 1, single centre, open label, escalating dose study to assess the safety, tolerability and immunogenicity of a therapeutic human papillomavirus (HPV) DNA vaccine (AMV002) for HPV-associated head and neck cancer (HNC)

Cancer Immunology, Immunotherapy, 2021-03, Vol.70 (3), p.743-753

2021

Link zum Volltext

Verfügbarkeit prüfen

Post-traumatic stress in head and neck cancer survivors and their partners

Supportive care in cancer, 2018-09, Vol.26 (9), p.3003-3011

2018

Link zum Volltext

Verfügbarkeit prüfen

Characteristics and impact of programmed death-ligand 1 expression, CD8+ tumor-infiltrating lymphocytes, and p16 status in head and neck squamous cell carcinoma

Medical oncology (Northwood, London, England), 2019-02, Vol.36 (2), p.21-10, Article 21

2019

Link zum Volltext

Verfügbarkeit prüfen

Patterns of care and impact of prognostic factors in the outcome of NUT midline carcinoma: a systematic review and individual patient data analysis of 119 cases

European archives of oto-rhino-laryngology, 2018-03, Vol.275 (3), p.815-821

2018

Link zum Volltext

Verfügbarkeit prüfen

Targeting cellular and molecular drivers of head and neck squamous cell carcinoma: current options and emerging perspectives

Cancer and metastasis reviews, 2016-09, Vol.35 (3), p.413-426

2016

Link zum Volltext

Verfügbarkeit prüfen

All-Exon TP53 Sequencing and Protein Phenotype Analysis Accurately Predict Clinical Outcome after Surgical Treatment of Head and Neck Squamous Cell Carcinoma

Annals of surgical oncology, 2019-07, Vol.26 (7), p.2294-2303

2019

Link zum Volltext

Verfügbarkeit prüfen

Early FDG PET at 10 or 20 Gy under chemoradiotherapy is prognostic for locoregional control and overall survival in patients with head and neck cancer

European journal of nuclear medicine and molecular imaging, 2011-07, Vol.38 (7), p.1203-1211

2011

Link zum Volltext

Verfügbarkeit prüfen

Remote triaging of urgent suspected head and neck cancer referrals: our experience during the first wave of the COVID-19 pandemic

European archives of oto-rhino-laryngology, 2022-02, Vol.279 (2), p.1111-1115

2022

Link zum Volltext

Verfügbarkeit prüfen

Metastatic head and neck cutaneous basal cell carcinomas: a retrospective observational study

Archives of Dermatological Research, 2021-08, Vol.313 (6), p.439-443

2021

Link zum Volltext

Verfügbarkeit prüfen

Proton Therapy for Head and Neck Cancer

Current treatment options in oncology, 2018-06, Vol.19 (6), p.28-14, Article 28

2018

Link zum Volltext

Verfügbarkeit prüfen

Elevated basal antibody-dependent cell-mediated cytotoxicity (ADCC) and high epidermal growth factor receptor (EGFR) expression predict favourable outcome in patients with locally advanced head and neck cancer treated with cetuximab and radiotherapy

Cancer Immunology, Immunotherapy, 2017-05, Vol.66 (5), p.573-579

2017

Link zum Volltext

Verfügbarkeit prüfen

Clinical and sociodemographic factors that affect the quality of life of survivors of head and neck cancer

Supportive care in cancer, 2020-04, Vol.28 (4), p.1941-1950

2020

Link zum Volltext

Verfügbarkeit prüfen

Telomeres and telomerase in head and neck squamous cell carcinoma: from pathogenesis to clinical implications

Cancer and metastasis reviews, 2016-09, Vol.35 (3), p.457-474

2016

Link zum Volltext

Verfügbarkeit prüfen

The hidden curve behind COVID-19 outbreak: the impact of delay in treatment initiation in cancer patients and how to mitigate the additional risk of dying—the head and neck cancer model

Cancer causes & control, 2021-05, Vol.32 (5), p.459-471

2021

Link zum Volltext

Verfügbarkeit prüfen

Immunologic and metabolic characteristics of HPV-negative and HPV-positive head and neck squamous cell carcinomas are strikingly different

Virchows Archiv : an international journal of pathology, 2014-09, Vol.465 (3), p.299-312

2014

Link zum Volltext

Verfügbarkeit prüfen

EORTC Quality of Life Questionnaire Head and Neck (H&N)-35 scores from H&N squamous cell carcinoma patients obtained at diagnosis and at 6, 9 and 12 months following diagnosis predict 10-year overall survival

European archives of oto-rhino-laryngology, 2019-12, Vol.276 (12), p.3495-3505

2019

Link zum Volltext

Verfügbarkeit prüfen

Modeling symptom drivers of oral intake in long-term head and neck cancer survivors

Supportive care in cancer, 2019-04, Vol.27 (4), p.1405-1415

2019

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 7.643

Suche als RSS-Feed

Aktive Filter

KollektionSpringerLINK Contemporary (Konsortium Baden-Württemberg)

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(7.488)
Mit Volltextzugriff
(7.269)

Publikationsform

Artikel
(7.637)
Tagungsberichte
(6)

Sprache

5 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Humans
(7.227)
Science & Technology
(6.561)
Life Sciences & Biomedicine
(6.552)
Medicine
(5.085)
Medicine & Public Health
(4.939)
Male
(4.049)
Female
(3.879)
Middle Aged
(3.454)
Otorhinolaryngology
(3.201)
Aged
(2.820)
Adult
(2.606)
Oncology
(2.492)
Head And Neck Surgery
(2.145)
Neurosurgery
(1.991)
Retrospective Studies
(1.586)
Head And Neck
(1.537)
Head And Neck Cancer
(1.506)
Head And Neck Neoplasms - Pathology
(1.492)
Head & Neck Cancer
(1.417)
Tumors
(1.252)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Overview of the 8th Edition TNM Classification for Head and Neck Cancer

EGFR-targeted therapies in the post-genomic era

Diagnostic performance of post-treatment FDG PET or FDG PET/CT imaging in head and neck cancer: a systematic review and meta-analysis

Correlation Between the Pretherapeutic Neutrophil to Lymphocyte Ratio and the Pathologic Response to Neoadjuvant Chemotherapy in Patients With Advanced Esophageal Cancer

Current Treatment Options for Metastatic Head and Neck Cancer

Optimal Dosing Strategy for Fluorescence-Guided Surgery with Panitumumab-IRDye800CW in Head and Neck Cancer

mTOR co-targeting strategies for head and neck cancer therapy

Risk factors for survival and distant metastasis in 125 patients with head and neck adenoid cystic carcinoma undergoing primary surgery

A phase 1, single centre, open label, escalating dose study to assess the safety, tolerability and immunogenicity of a therapeutic human papillomavirus (HPV) DNA vaccine (AMV002) for HPV-associated head and neck cancer (HNC)

Post-traumatic stress in head and neck cancer survivors and their partners

Characteristics and impact of programmed death-ligand 1 expression, CD8+ tumor-infiltrating lymphocytes, and p16 status in head and neck squamous cell carcinoma

Patterns of care and impact of prognostic factors in the outcome of NUT midline carcinoma: a systematic review and individual patient data analysis of 119 cases

Targeting cellular and molecular drivers of head and neck squamous cell carcinoma: current options and emerging perspectives

All-Exon TP53 Sequencing and Protein Phenotype Analysis Accurately Predict Clinical Outcome after Surgical Treatment of Head and Neck Squamous Cell Carcinoma

Early FDG PET at 10 or 20 Gy under chemoradiotherapy is prognostic for locoregional control and overall survival in patients with head and neck cancer

Remote triaging of urgent suspected head and neck cancer referrals: our experience during the first wave of the COVID-19 pandemic

Metastatic head and neck cutaneous basal cell carcinomas: a retrospective observational study

Proton Therapy for Head and Neck Cancer

Elevated basal antibody-dependent cell-mediated cytotoxicity (ADCC) and high epidermal growth factor receptor (EGFR) expression predict favourable outcome in patients with locally advanced head and neck cancer treated with cetuximab and radiotherapy

Clinical and sociodemographic factors that affect the quality of life of survivors of head and neck cancer

Telomeres and telomerase in head and neck squamous cell carcinoma: from pathogenesis to clinical implications

The hidden curve behind COVID-19 outbreak: the impact of delay in treatment initiation in cancer patients and how to mitigate the additional risk of dying—the head and neck cancer model

Immunologic and metabolic characteristics of HPV-negative and HPV-positive head and neck squamous cell carcinomas are strikingly different

EORTC Quality of Life Questionnaire Head and Neck (H&N)-35 scores from H&N squamous cell carcinoma patients obtained at diagnosis and at 6, 9 and 12 months following diagnosis predict 10-year overall survival

Modeling symptom drivers of oral intake in long-term head and neck cancer survivors

Aktive Filter

Suchergebnisse filtern